01962nas a2200205   4500000000100000008004100001260001200042653001700054653001200071100001200083700001400095700001300109700001600122700001400138245011200152300001400264490000700278520145700285022001401742       2023                            d  c01/202310aMisdiagnosis10aLeprosy1 aNeves K1 aMachado L1 aLisboa M1 aSteinmann P1 aIgnotti E00aSelf-reported clinical history of misdiagnosed leprosy cases in the State of Mato Grosso, Brzil, 2016-2019.  ae002794210 v393 a<p>This study aimed to analyze the self-reported clinical history of patients misdiagnosed with leprosy in the State of Mato Grosso, Brazil. This is a cross-sectional study of new leprosy cases diagnosed in the State of Mato Grosso from 2016 to 2019, with individuals who were released from multidrug therapy due to misdiagnosis after starting treatment. Data were collected via telephone interviews. Over the study period, 354 leprosy cases were released from treatment due to misdiagnosis, of which 162 (45.8%) could be interviewed. All interviewees expressed dissatisfaction with their treatment, which prompted them to seek a reevaluation of their diagnosis before they were released due to "misdiagnosis". Among them, 35.8% received a final diagnosis of a musculoskeletal or connective tissue disease - mainly fibromyalgia and degenerative changes in the spine - followed by 13.6% with diagnoses of skin and subcutaneous tissue diseases. For 23.5% of the respondents, no alternative diagnosis was established, whereas 7.4% were later re-diagnosed with leprosy. Fibromyalgia and spinal problems were the most common alternative diagnoses for erroneous leprosy. Although the diagnosis of leprosy is usually clinical and does not require access to technical infrastructure in most cases, some more complex situations require diagnostic support via complementary tests, as well as close collaboration between primary care and reference services.</p>
  a1678-4464